Buy Clopidogrel
Clopidogrel

0.53
Clopidogrel (Clopidogrel Bisulfate) is an antiplatelet medication used to prevent blood clots in patients who have recently experienced a heart attack or stroke. By preventing platelets from sticking together, it reduces the risk of serious cardiovascular events in adults with established heart disease.


Availability
In Stock
Delivery Time
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Active Ingredient(s)
Clopidogrel Bisulfate
Reference Brand
Plavix
Manufacturer
Various
Product Form
Tablet
Regulatory Classification
Rx
Primary Category
Blood Thinner
Product Category
Antithrombotic agents, Platelet aggregation inhibitors
Pharmacological Class
Thienopyridines
Manufacturer Description
A medication taken to prevent blood clots in people at high risk of heart attacks or strokes.
Mechanism of Action
Clopidogrel prevents platelets in the blood from sticking together to form clots. By inhibiting platelet aggregation, it helps maintain blood flow and reduces the risk of serious cardiovascular events.
Route of Administration
Oral
Onset Time
2 hours
Duration
7-10 days (life of the platelet)
Contraindications
Active bleeding (e.g., stomach ulcer), Severe liver disease
Severe Adverse Events
Uncontrolled bleeding, Blood in urine or stools, TTP (blood disorder), Hepatitis
Common Side Effects
Easy bruising, Minor nosebleeds
Uncommon Side Effects
Diarrhoea, Abdominal pain, Indigestion
Drug Interactions
Aspirin, NSAIDs (Ibuprofen), Warfarin, Omeprazole, SSRIs
Pregnancy Safety Warnings
Generally not recommended unless essential and prescribed by a specialist.
Age Restrictions
Adults only
Storage Guidelines
Store in a dry place at room temperature.
Related Products
Plavix, Ticagrelor, Prasugrel

Clopidogrel FAQ

What should I do if I experience a nosebleed while taking clopidogrel?

Apply firm pressure to the nostrils for at least 10 minutes. If bleeding persists for more than 20 minutes or is recurrent, seek medical evaluation as it may indicate excessive anticoagulation.

Can I take clopidogrel with aspirin?

Yes, many clinicians prescribe clopidogrel together with low-dose aspirin (dual antiplatelet therapy) after certain heart procedures. This combination increases bleeding risk, so regular monitoring is essential.

Is it safe to travel internationally with clopidogrel tablets?

Carry the medication in its original packaging with a copy of the prescription. In the UK, clopidogrel is a prescription-only medicine, so you may need a letter from your doctor when crossing borders.

Do I need to fast before taking my clopidogrel pill?

No fasting is required. The tablet can be taken with or without food, but taking it with a meal may reduce stomach irritation.

How does clopidogrel differ from aspirin in preventing clots?

Aspirin blocks the thromboxane A2 pathway, while clopidogrel blocks the ADP-P2Y12 pathway. The two mechanisms are complementary, which is why they are often used together for stronger protection.

Can over-the-counter herbal supplements affect clopidogrel?

Certain herbs such as ginkgo biloba, garlic, or high-dose omega-3 fish oils can increase bleeding tendency. Discuss any supplements with your doctor before starting clopidogrel.

What is the impact of proton-pump inhibitors (PPIs) on clopidogrel effectiveness?

PPIs like omeprazole inhibit CYP2C19, the enzyme needed to activate clopidogrel, potentially reducing its antiplatelet effect. If a PPI is required, alternatives such as pantoprazole may be preferred.

Is clopidogrel covered by the NHS, and how much does it cost?

Clopidogrel is generally prescribed on the NHS and may be supplied free of charge for eligible patients. Exact costs depend on the prescribing doctor’s decision and patient’s exemption status.

Can I stop clopidogrel abruptly if I feel better?

Stopping clopidogrel without medical advice can raise the risk of clot formation, especially after recent cardiac events or stent placement. Any discontinuation should be discussed with a healthcare professional.

Clopidogrel Bisulfate: Generic Medication Overview

Clopidogrel Bisulfate is an antiplatelet medication used to reduce the risk of blood clots that can cause heart attacks, strokes, or peripheral arterial disease. It is available as a 75 mg oral pill and is prescribed in the United Kingdom under the NHS. Generic clopidogrel is produced by several pharmaceutical manufacturers and is also marketed under brand names such as Plavix. The drug is classified in the “Heart & Blood Pressure” therapeutic area and is a prescription-only medicine (Rx) according to the Medicines and Healthcare products Regulatory Agency (MHRA).

How Clopidogrel Works in the Body

Clopidogrel is a P2Y12 receptor inhibitor. After oral ingestion, the pro-drug is converted in the liver by the CYP2C19 enzyme into its active metabolite. This active form binds irreversibly to the P2Y12 ADP receptor on the surface of platelets, blocking ADP-mediated activation of the glycoprotein IIb/IIIa complex.

  • Result: Platelets cannot clump together (aggregate) to form a clot.
  • Onset: Antiplatelet effect begins within 2 hours, reaching maximum inhibition after 3-7 days of daily dosing because new platelets must be generated to restore function.
  • Duration: Because the inhibition is irreversible, the effect lasts for the lifespan of the platelet (≈7-10 days), even after the drug is stopped.

By dampening platelet aggregation, clopidogrel lowers the chance that a ruptured atherosclerotic plaque will trigger an occluding clot in coronary, cerebral, or peripheral vessels.

Conditions Treated by Clopidogrel

Clopidogrel is approved by the UK’s MHRA and incorporated into NICE (National Institute for Health and Care Excellence) guidelines for the following indications:

  • Secondary prevention of non-fatal myocardial infarction (heart attack) and ischemic stroke in patients with established atherosclerotic disease.
  • Acute coronary syndrome (ACS), including unstable angina and non-ST-segment elevation myocardial infarction (NSTEMI), usually in combination with aspirin (dual antiplatelet therapy).
  • After percutaneous coronary intervention (PCI) with stent placement to prevent stent thrombosis.
  • Symptomatic peripheral arterial disease (PAD) to reduce limb-related events.

Typical patients are adults with a history of cardiovascular events or those undergoing coronary procedures who require long-term antiplatelet protection.

Off-Label and Investigational Uses

Some clinicians consider clopidogrel for off-label situations such as:

  • Secondary prevention after coronary artery bypass graft (CABG) surgery when aspirin alone is insufficient.
  • Prevention of recurrent venous thromboembolism in patients who cannot tolerate oral anticoagulants.

These uses are not formally approved by the MHRA and should only be undertaken under specialist supervision, with careful risk-benefit assessment.

Evaluating Clopidogrel for Your Health Profile

Who Should Use It

  • Adults with documented coronary artery disease, prior stroke/TIA, or PAD.
  • Patients who have received a drug-eluting stent and need dual antiplatelet therapy.

Absolute Contraindications

  • Active pathological bleeding (e.g., gastrointestinal ulcer bleeding, intracranial hemorrhage).
  • Known hypersensitivity to clopidogrel, any component of the tablet, or other thienopyridine antiplatelets (e.g., ticlopidine).

Relative Contraindications & Cautions

  • History of peptic ulcer disease - may require gastro-protective therapy.
  • Severe hepatic impairment - reduced conversion to the active metabolite.
  • Concurrent use of anticoagulants (warfarin, DOACs) - heightened bleeding risk.
  • Pregnancy & lactation - limited data; clopidogrel should be used only if the potential benefit justifies the potential risk to the fetus or infant.
  • Pediatric patients - safety and efficacy not established; not recommended.

Special Populations

  • Elderly (≥ 75 years) - increased bleeding propensity; dose remains 75 mg daily but monitoring is essential.
  • Renal impairment - no dose adjustment required for mild-to-moderate disease, but severe renal failure warrants close observation.

Safety Profile: Side Effects and Interactions

Common Side Effects

  • Minor bleeding (bruising, nosebleeds, gum bleeding) - commonly reported.
  • Gastro-intestinal discomfort (indigestion, nausea).
  • Skin rash or itching.
  • Diarrhoea or abdominal pain.

Serious Adverse Events

  • Severe or life-threatening bleeding: intracranial haemorrhage, gastrointestinal haemorrhage, hematuria.
  • Thrombotic thrombocytopenic purpura (TTP) - rare but may be fatal.
  • Agranulocytosis or severe neutropenia - very uncommon.
  • Allergic reactions: angio-oedema, anaphylaxis.

Any sudden, unexplained bleeding or severe rash should prompt immediate medical attention.

Drug Interactions

| Interaction Type | Example(s) | Clinical Impact | |||--| | Major | Omeprazole, Esomeprazole (CYP2C19 inhibitors) | Decrease activation of clopidogrel, possibly reducing antiplatelet effect. | | | Warfarin, Apixaban, Rivaroxaban (anticoagulants) | Additive bleeding risk - monitor INR or DOAC-specific assays. | | Moderate | NSAIDs (e.g., ibuprofen, diclofenac) | Increase gastrointestinal bleeding risk. | | | SSRIs (e.g., fluoxetine, sertraline) | Heighten risk of mucosal bleeding. | | | CYP2C19 strong inhibitors (e.g., fluconazole, voriconazole) | Similar to PPIs - may diminish clopidogrel efficacy. | | Food/Lifestyle | Alcohol (excessive) | Potentiates bleeding; advise moderation. | | | Grapefruit juice | No clinically relevant interaction reported. |

Patient Advice: Always provide your healthcare professional with a complete list of prescribed medicines, over-the-counter products, supplements, and herbal remedies before starting clopidogrel.

Food and Lifestyle Interactions

  • Clopidogrel can be taken with or without food; swallowing the tablet whole is recommended.
  • Alcohol does not affect clopidogrel metabolism but can increase overall bleeding tendency.
  • No known impact on driving or the use of machinery.

How to Take Clopidogrel

  • Standard dose: 75 mg once daily, taken at the same time each day.
  • Administration: Swallow the pill whole with a glass of water. No need to take with food, but taking it with a meal can reduce stomach upset.
  • Missed dose: If you remember within 12 hours, take it as soon as possible. If it is near the time of the next dose, skip the missed pill and continue with the regular schedule. Do not double-dose.
  • Overdose: Symptoms may include excessive bruising, nosebleeds, black stools, or vomiting blood. Seek urgent medical care; treatment may involve platelet transfusion and supportive measures.
  • Discontinuation: Stopping clopidogrel abruptly can increase the risk of clot formation, especially after recent coronary stent placement. Any change should be directed by a physician, who may switch to another antiplatelet or adjust therapy.

Renal or hepatic adjustment: No routine dose change is required for mild-to-moderate kidney or liver disease, but clinicians may monitor more closely in severe impairment.

Monitoring and Follow-Up

  • Baseline labs: Full blood count (to assess platelet count), liver function tests, and renal profile before initiating therapy.
  • During therapy: Periodic CBC (especially if combined with anticoagulants) to detect occult bleeding or thrombocytopenia.
  • Clinical review: Within 1-2 weeks of starting clopidogrel to evaluate adherence, side effects, and any new bleeding signs. Subsequent reviews are usually scheduled at 3-month intervals or sooner if problems arise.
  • Special situations: Patients on dual antiplatelet therapy (aspirin + clopidogrel) after PCI should have regular assessment for bleeding, especially if they are elderly or have a history of ulcer disease.

Storage and Handling

  • Keep the tablets in the original blister pack until use.
  • Store at room temperature (15-30 °C), away from direct sunlight, moisture, and heat.
  • Do not refrigerate or freeze.
  • Keep out of reach of children and pets.
  • Dispose of unused medication according to local pharmacy take-back schemes or the NHS “Find a Medicine Disposal” service.

Medication-Specific Glossary

P2Y12 Inhibitor
A class of drugs that block the platelet P2Y12 ADP receptor, preventing platelet activation and aggregation.
Irreversible Inhibition
Permanent binding to a target enzyme or receptor; normal function resumes only after new platelets are produced.
Platelet Aggregation
The process by which platelets clump together to form a clot; essential for stopping bleeding but can cause harmful blockages in arteries.
CYP2C19
A liver enzyme that converts clopidogrel into its active metabolite; certain drugs can inhibit this enzyme, reducing clopidogrel’s effectiveness.
Dual Antiplatelet Therapy (DAPT)
The combined use of clopidogrel with aspirin to provide stronger protection against clot formation, commonly prescribed after coronary stent placement.

Medical Disclaimer

This article provides educational information about clopidogrel and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Information for Clopidogrel is sourced from established medical standards and updated frequently. It is provided for general guidance and should be confirmed with a healthcare professional before use.
Categories
Waar kunt u Cardiovasculaire Gezondheid bestellen - Clopidogrel bestellen Prescription options for Impotence Treatment Tablets: - Tadalafil ED 36-Hour Cialis Generic